{
  "image_filename": "figure_p1_det_0_003.png",
  "image_path": "Grohskopf_et_al.__2023_/extracted/figures/figure_p1_det_0_003.png",
  "image_type": "Figure",
  "page_number": 1,
  "block_id": "det_0_003",
  "claim_id": "claim_005",
  "claim": "Flublok (quadrivalent) was evaluated in the pivotal trial against Fluarix (quadrivalent standard-dose vaccine).",
  "supports_claim": false,
  "explanation": "A black background displaying the U.S. Department of Health & Human Services seal and the CDC logo, with no additional text or data. The image contains only the HHS and CDC logos and does not present any study design, vaccine names, or comparison data, and thus doesn't support the claim. Note: Analysis is limited by the content visible, which is solely branding without any clinical information.",
  "model_used": "o4-mini",
  "detailed_analysis": {
    "supports_claim": false,
    "image_description": "A black background displaying the U.S. Department of Health & Human Services seal and the CDC logo, with no additional text or data.",
    "evidence_found": null,
    "reasoning": "The image contains only the HHS and CDC logos and does not present any study design, vaccine names, or comparison data, and thus doesn't support the claim.",
    "confidence_notes": "Analysis is limited by the content visible, which is solely branding without any clinical information."
  }
}